Global mortality from conditions with skin manifestations

Journal of the American Academy of Dermatology

Volumn 71, Issue 6, 2014, Pages 1137-1143.e17

  Boyers, Lindsay N ^a   Karimkhani, Chante ^b   Naghavi, Mohsen ^c   Sherwood, David ^d   Margolis, David J ^e   Hay, Roderick J ^f   Williams, Hywel C ^g   Naldi, Luigi ^h   Coffeng, Luc E ^c   Weinstock, Martin A ^i,j,k   Dunnick, Cory A ^l,m   Pederson, Hannah ^l   Vos, Theo ^c   Dellavalle, Robert P ^l,m,n  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia University College of Physicians and Surgns ^*  (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f KING S COLLEGE HOSPITAL   (United Kingdom)

^g UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^h Hospital Papa Giovanni XXIII   (Italy)

ⁱ PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j RHODE ISLAND HOSPITAL   (United States)

^k BROWN UNIVERSITY   (United States)

^l UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^m DEPARTMENT OF VETERANS AFFAIRS   (United States)

ⁿ UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

basal cell carcinoma; burden of disease; dermatology; developed countries; developing countries; epidemiology Global Burden of Disease Study 2010; measles; melanoma; mortality; nonmelanoma skin cancer; rate of death; squamous cell carcinoma; syphilis

Indexed keywords

ARTICLE; BACTERIAL SKIN DISEASE; BASAL CELL CARCINOMA; CELLULITIS; CHICKENPOX; CROSS-SECTIONAL STUDY; DECUBITUS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; HUMAN; MEASLES; MELANOMA; MORTALITY; PRIORITY JOURNAL; SKIN DISEASE; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; SYPHILIS; AGE DISTRIBUTION; COMPARATIVE STUDY; DENGUE; HEALTH; SKIN TUMOR;

AGE DISTRIBUTION; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CHICKENPOX; CROSS-SECTIONAL STUDIES; DENGUE; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; GLOBAL HEALTH; HUMANS; MEASLES; MELANOMA; SKIN NEOPLASMS; SYPHILIS;

EID: 84922499398     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.08.022     Document Type: Article

References (46)

1. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, and V. Aboyans Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
2. C.J. Murray, and A.D. Lopez Measuring the global burden of disease N Engl J Med 369 2013 448 457
3. US Burden of Disease Collaborators The state of US health, 1990-2010: burden of diseases, injuries, and risk factors JAMA 310 2013 591 608
4. T. Vos, A.D. Flaxman, M. Naghavi, R. Lozano, C. Michaud, and M. Ezzati Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2163 2196
5. C.J. Murray, and A.D. Lopez Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study Lancet 349 1997 1436 1442
6. R.J. Hay, N.E. Johns, H.C. Williams, I.W. Bolliger, R.P. Dellavalle, and D.J. Margolis The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions J Invest Dermatol 134 2014 1527 1534
7. N. Soleman, D. Chandramohan, and K. Shibuya Verbal autopsy: current practices and challenges Bull World Health Organ 84 2006 239 245
8. H. Wang, L. Dwyer-Lindgren, K.T. Lofgren, J.K. Rajaratnam, J.R. Marcus, and A. Levin-Rector Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2071 2094
9. C.J.L. Murray, M. Ezzati, A.D. Flaxman, S. Lim, R. Lozano, and C. Michaud GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology Lancet 380 2012 2055 2058
10. J.K. Rajaratnam, L.N. Tran, A.D. Lopez, and C.J.L. Murray Measuring under-five mortality: validation of new low-cost methods PLoS Med 7 2010 e1000253
11. Z. Obermeyer, J.K. Rajaratnam, C.H. Park, E. Gakidou, M.C. Hogan, and A.D. Lopez Measuring adult mortality using sibling survival: a new analytical method and new results for 44 countries, 1974-2006 PLoS Med 7 2010 e1000260
12. C.J.L. Murray, J.K. Rajaratnam, J. Marcus, T. Laakso, and A.D. Lopez What can we conclude from death registration? Improved methods for evaluating completeness PLoS Med 7 2010 e1000262
13. J.K. Rajaratnam, J.R. Marcus, A.D. Flaxman, H. Wang, A. Levin-Rector, and L. Dwyer Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4 Lancet 375 2010 1988 2008
14. M. Naghavi, S. Makela, K. Foreman, J. O'Brien, F. Pourmalek, and R. Lozano Algorithms for enhancing public health utility of national causes-of-death data Popul Health Metr 8 2010 9
15. K.J. Foreman, R. Lozano, A.D. Lopez, and C.J. Murray Modeling causes of death: an integrated approach using CODEm Popul Health Metr 10 2012 1
16. TedMed. What does a $100 million public health data revolution look like? Available from: URL: http://www.tedmed.com/talks/show?id=17751. Accessed April 30, 2014.
17. C.J.L. Murray, M. Ezzati, A.D. Flaxman, S. Lim, R. Lozano, and C. Michaud Supplementary appendix to: GBD 2010: design, definitions, and metrics Lancet 380 2012 263 266
18. R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya, and V. Aboyans Supplementary appendix to: global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
19. P. Das, and U. Samarasekera The story of GBD 2010: a "super-human" effort Lancet 380 2012 2067 2070
20. M. Ng, M.K. Freeman, T.D. Fleming, M. Robinson, L. Dwyer-Lindgren, and B. Thomson Supplementary appendix to: Smoking prevalence and cigarette consumption in 187 countries, 1980-2012 JAMA 311 2014 183 192
21. Institute for Health Metrics and Evaluation. Country profiles. Available from: URL: http://ghdx.healthmetricsandevaluation.org/country-profiles. Accessed May 1, 2014.
22. L. Lemus-Deschamps, L. Rikus, S. Grainger, P. Gies, J. Sisson, and Z. Li UV index and UV dose distributions for Australia (1997-2001) AMOJ 53 2004 239 250
23. G. Bentham, and A. Aase Incidence of malignant melanoma of the skin in Norway, 1955-1989: associations with solar ultraviolet radiation, income and holidays abroad Int J Epidemiol 25 1996 1132 1138
24. A.M. Forsea, V. Del Marmol, E. de Vries, E.E. Bailey, and A.C. Geller Melanoma incidence and mortality in Europe: new estimates, persistent disparities Br J Dermatol 167 2012 1124 1130
25. D.B. Buller, V. Cokkinides, H.I. Hall, A.M. Hartman, M. Saraiya, and E. Miller Prevalence of sunburn, sun protection, and indoor tanning behaviors among Americans: review from national surveys and case studies of 3 states J Am Acad Dermatol 65 Suppl 2011 S114 S123
26. H.T. Kwon, J.A. Mayer, K.K. Walker, H. Yu, E.C. Lewis, and G.E. Belch Promotion of frequent tanning sessions by indoor tanning facilities: two studies J Am Acad Dermatol 46 2002 700 705
27. US Department of Health and Human Services, Public Health Service, National Toxicology Program. Report on carcinogens. 12th ed. Exposure to sunlamps or sunbeds. Available from: URL: http://ntp.niehs.nih.gov/?objectid=03C9AF75-E1BF-FF40-DBA9EC0928DF8B15. Accessed January 19, 2014.
28. F. El Ghissassi, R. Baan, K. Straif, Y. Grosse, B. Secretan, and V. Bouvard A review of human carcinogens-part D: radiation Lancet Oncol 10 2009 751 752
29. S. Gandini, F. Sera, M.S. Cattaruzza, P. Pasquini, O. Picconi, and P. Boyle Meta-analysis of risk factors for cutaneous melanoma II: sun exposure Eur J Cancer 41 2005 45 60
30. D.U. Ekwueme, G.P. Guy, C. Li, S.H. Rim, P. Parelkar, and S.C. Chen The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006 J Am Acad Dermatol 65 Suppl 2011 S133 S143
31. K. Lewis, and M.A. Weinstock Nonmelanoma skin cancer mortality, 1988 to 2000: the Rhode Island follow-back study Arch Dermatol 140 2004 837 842
32. K.G. Lewis, and M.A. Weinstock Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000 J Invest Dermatol 127 2007 2323 2327
33. W.J. Moss, and D.E. Griffin Measles Lancet 379 2012 153 164
34. C.A. de Quadros, J.K. Andrus, M.C. Danovaro-Holliday, and C. Castillo-Solorzano Feasibility of global measles eradication after interruption of transmission in the Americas Expert Rev Vaccines 7 2008 355 362
35. F.T. Cutts, J. Lessler, and C.J. Metcalf Measles elimination: progress, challenges and implications for rubella control Expert Rev Vaccines 12 2013 917 932
36. Centers for Disease Control and Prevention Progress toward measles control-African region, 2001-2008 Morb Mortal Wkly Rep 58 2009 1036 1041
37. Centers for Disease Control and Prevention Measles outbreaks and progress toward measles preelimination-African Region, 2009-2010 Morb Mortal Wkly Rep 60 2011 374 378
38. World Health Organization Regional Committee for Africa. Towards the elimination of measles in the African region by 2020: report of the regional director. Available from: URL: http://www.afro.who.int/en/fifty-ninth-session.html. Accessed January 19, 2014.
39. M.J. Papania, G.S. Wallace, P.A. Rota, J.P. Icenogle, A.P. Fiebelkorn, and G.L. Armstrong Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience JAMA Pediatr 168 2014 148 155
40. Centers for Disease Control and Prevention. Measles cases and outbreaks, January 1 to June 13, 2014. Available from: URL: http://www.cdc.gov/measles/cases-outbreaks.html. Accessed June 18, 2014.
41. Centers for Disease Control and Prevention. Measles cases in the United States reach 20-year high. Available from: URL: http://www.cdc.gov/media/releases/2014/p0529-measles.html. Accessed June 18, 2014.
42. S.E. Cohen, J.D. Klausner, J. Engelman, and S. Philip Syphilis in the modern era: an update for physicians Infect Dis Clin North Am 27 2013 705 722
43. C.E. Cameron, and S.A. Lukehart Current status of syphilis vaccine development: need, challenges, prospects Vaccine 32 2014 1602 1609
44. G.P. Schmid, B.P. Stoner, S. Hawkes, and N. Broutet The need and plan for global elimination of congenital syphilis Sex Transm Dis 34 Suppl 2007 S5 10
45. World Health Organization. The global elimination of congenital syphilis: rationale and strategy for action. Available from: URL: http://whqlibdoc.who.int/publications/2007/9789241595858-eng.pdf?ua=1. Accessed January 19, 2014.
46. V. Madan, J.T. Lear, and R.M. Szeimies Non-melanoma skin cancer Lancet 375 2010 673 685